Phase 1 Nonsmall Cell Lung Cancer Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Breast CancerCervical CancerColon Cancer+4 more

Orano Med LLC48 enrolled4 locationsNCT05283330

Recruiting

Phase 1

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

University of California, Davis40 enrolled1 locationNCT06228482

Recruiting

Phase 1

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

Solid Tumor, AdultNonsmall Cell Lung Cancer

Second Affiliated Hospital of Guangzhou Medical University30 enrolled1 locationNCT03778814